Collectively, these data implicated that LXN deficiency increased PD-L2+ macrophages and decreased T cells infiltration in colorectal cancer tissues, suggesting LXN deficiency enhances pro-tumor immune response in mice. The gene discussed is LXN; the disease is neoplasm.